(Q34157250)

31 July 2017

1 reference

title

Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma (English)

1 reference

31 July 2017

1 reference

0 references

1 reference

Michael C Kew

1

1 reference

31 July 2017

publication date

1 January 2011

1 reference

Journal of Gastroenterology and Hepatology

31 July 2017

published in

1 reference

31 July 2017

volume

26 Suppl 1

1 reference

31 July 2017

page(s)

144-152

1 reference

Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06546.X

Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06546.X

Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06546.X

DNA ends: maintenance of chromosome termini versus repair of double strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06546.X

Upregulation of human telomerase reverse transcriptase mRNA expression by in vitro transfection of hepatitis B virus X gene into human hepatocarcinoma and cholangiocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06546.X

A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06546.X

Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06546.X

10.1111/J.1440-1746.2010.06546.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference